Xsulin R Eris1pen Injection

It is suitable for use in both type 1 and type 2 diabetes patients who do not achieve adequate glycemic control with oral hypoglycemic agents alone. The onset of action typically occurs within 30 minutes, with a peak effect at 2 to 4 hours and a duration of action lasting approximately 6 to 8 hours, making it ideal for mealtime glucose regulation. Dose adjustments should be individualized based on blood glucose monitoring, dietary intake, and physical activity.

Hypoglycemia is the most common adverse effect and requires prompt recognition and management. Patients should be educated on proper injection techniques, storage conditions, and the importance of adherence to prescribed regimens. Xsulin R Eris1pen Injection should be used under medical supervision, with periodic monitoring of blood glucose and HbA1c levels to optimize therapeutic outcomes.